Blackstone Group »

Aclaris Therapeutics shares owned by Blackstone Group

Quarter-by-quarter ownership of Aclaris Therapeutics (ACRS) shares owned by Blackstone Group from 13F filings

Historical chart of Blackstone Group investment in Aclaris Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aclaris Therapeutics held by Blackstone Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aclaris Therapeutics by Blackstone Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $14k 13k 1.05
2023-09-30 $8.6M 1.3M 6.85
2023-06-30 $135k 13k 10.37
2023-03-31 $105k 13k 8.09
2022-12-31 $205k 13k 15.75
2022-09-30 $205k 13k 15.73
2022-06-30 $182k 13k 13.96
2022-03-31 $225k 13k 17.26
2021-12-31 $189k 13k 14.50